Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
3.690
+0.010 (0.27%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Fulcrum Therapeutics Market Cap
Fulcrum Therapeutics has a market cap or net worth of $281.54 million as of October 2, 2026. Its market cap has decreased by -44.21% in one year.
Market Cap
281.54M
Enterprise Value
-32.03M
1-Year Change
-44.21%
Ranking
Category
Stock Price
$3.69
ChartMarket Cap Chart
Since July 18, 2019, Fulcrum Therapeutics's market cap has decreased from $301.64M to $281.54M, a decrease of -6.67%. That is a compound annual growth rate of -0.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 281.54M | -62.27% |
| Dec 31, 2025 | 746.12M | 194.32% |
| Dec 31, 2024 | 253.51M | -39.25% |
| Dec 29, 2023 | 417.30M | 10.13% |
| Dec 30, 2022 | 378.93M | -47.15% |
| Dec 31, 2021 | 716.95M | 124.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abeona Therapeutics | 285.92M |
| Upstream Bio | 284.26M |
| Clinuvel Pharmaceuticals | 282.75M |
| Vogenx | 280.17M |
| EyePoint | 279.33M |
| Rocket Pharmaceuticals | 278.83M |
| X4 Pharmaceuticals | 277.61M |
| Vanda Pharmaceuticals | 277.22M |